即使是规模最大的长期研究（SOS）也显示，手术患者仍比一般人群早死 5.5 年。
原始表述
حتى أكبر تجربة طويلة الأمد (SOS) أظهرت أن مرضى الجراحة يموتون قبل عامة السكان بـ 5.5 سنوات.
按来源为原话. 译文由本项目提供；以阿拉伯语原文为准。
译文
即使是规模最大的长期研究（SOS）也显示，手术患者仍比一般人群早死 5.5 年。
出处
- 来源状态
- 档案网站编辑
- 归属
- Archive editors (eltayebat.com); not necessarily Elawady's own words
- 出处
- https://eltayebat.com/rule/bariatric-surgery/
- 归属的不确定性
- Editorial summary/narrative and study selection written by the archive operators; the archive states that the cited research documents harm independently of Dr. Diaa's words.
- 所声称的机制
Implied: surgery does not restore normal survival.
- 所声称的健康影响
Shorter life than general population.
- 涉及人群
SOS participants
- Elawady 设定的地域限制
not applicable
科学评估
基本正确 – 核心内容正确，但有局限或细微不准确之处。
证据确定性: 高 – 进一步研究极不可能改变该评估。
1. 说法是什么？
SOS patients die 5.5 years earlier than the general population.
2. 哪些内容可证实是正确的？
Correct: adjusted median life expectancy in the surgery group was 5.5 years shorter than in the general population, and 3.0 years longer than in usual care (A-BAR-05).
3. 哪些内容是错误或夸大的？
Read alone, the summary suggests surgery shortens life. The full text shows the non-operated obesity group had an 8.5-year shorter life expectancy; surgery reduced the gap. The authors attribute the remaining gap to persistent above-normal BMI, irreversible metabolic damage, surgical complications and other causes (alcoholism, suicide, trauma).
4. 哪些内容仍不明确？
Whether modern procedures narrow the gap more.
5. 哪些研究支持该说法？
A-BAR-05; Nordic registry confirms operated patients still have about twice the general-population mortality (SMR 1.94, I-BAR-104).
6. 哪些研究与该说法相矛盾？
A-BAR-05 (full context), I-BAR-01, I-BAR-10; I-BAR-104 (all-cause HR 0.63 vs obese non-operated people); I-BAR-106 (16% lower mortality over up to 40 years).
7. 对德国和欧洲而言情况如何？
Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.
8. 关于埃及的已知情况是什么？
No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.
9. 合理的实际结论是什么？
减重手术能改善但不能使重度肥胖者的预期寿命恢复正常。
评估详情
- 证据确定性的依据
Number directly reported in the NEJM abstract and full text; interpretation issue only.
- 来源质量
The number is correct. The summary omits that controls lived about 8.5 years less than the general population, so surgery narrowed the gap by 3 years; SOS is a non-randomized controlled study, not a randomized 'trial'. The narrative and featured card report both numbers correctly.
- 地区可推广性
Swedish data.
- 个体例外情况
Not applicable.
- 说法的地域范围
- 普遍性（生物学/医学）
- 最近审核
- 2026年10月26日 初步
科学证据详解
有充分科学证据支持 – 该说法与一致的高质量证据相符。
研究问题: In the SOS study, did surgery patients die about 5.5 years earlier than the general population, and does this mean surgery shortens life?
研究问题详解 (PICO)
- 人群
- SOS participants with obesity
- 干预或暴露
- Bariatric surgery
- 对照
- General population; matched obese usual-care controls
- 地域范围
- universal (Swedish data)
- 结局指标
- Life expectancy
- Standardised mortality
研究结果按作者报告呈现。我们的评估见下文。
哪些证据支持该说法？
Swedish 24-year study: surgery added about 3 years of life
SOS: life expectancy after surgery 5.5 years shorter than general population.
- 实际结果
- -5.5 years (3.4-7.6) vs general population; +3.0 years vs usual care.
- 方法学质量
- moderate-high
- 相关性
- direct
- 局限
- Non-randomised
Nordic study: survival after obesity surgery
Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048 队列研究已核查摘要新增Nordic registry: operated patients still have about twice the general-population mortality.
- 实际结果
- SMR 1.94 (1.83-2.05).
- 方法学质量
- moderate
- 相关性
- direct for the number
- 局限
- Registry
哪些证据不支持该说法？
Swedish 24-year study: surgery added about 3 years of life
Same study: usual-care controls lived 8.5 years less than the general population; surgery narrowed the gap.
- 实际结果
- +3.0 years vs controls.
- 方法学质量
- moderate-high
- 相关性
- direct - contradicts the implied causal message
- 局限
- Non-randomised
Meta-analysis: weight-loss surgery and survival
Meta-analysis: +6.1 years median life expectancy vs matched controls.
- 实际结果
- HR ~0.51.
- 方法学质量
- moderate-high
- 相关性
- direct
- 局限
- Observational
总体证据说明了什么？
基于上述研究的编辑评估——其本身并非研究结果。
哪种观点有更好的证据支持？
The 5.5-year figure is correct; the remaining gap reflects severe obesity and its consequences, not harm from surgery.
为什么有些研究权重更大
Same primary source for both readings; Nordic registry confirms the pattern.
因果关系是否已确立？ 不适用 The claim reports a descriptive number.
仍存在的不确定性
Whether modern procedures narrow the gap further.
合理的结论
Number correct; implied conclusion misleading.
为什么研究结果看起来互相矛盾？
None: comparisons with the general population and with obese controls answer different questions (see C-BAR-01).
这是否取决于国家？
- 一般生物学效应
- Universal.
- 饮食习惯
- Not applicable (surgical procedure, not a food).
- 食品原产地
- Not applicable (surgical procedure, not a food).
- 污染物
- Not applicable (surgical procedure, not a food).
- 本国生产条件
- Not applicable.
- 法律规则
- Not applicable.
- 实际监测数据
- Not applicable.
足以改变结论的地区差异没有可靠数据支持。
统计复核
- Life-years gained and share of gap closed – 8.5 - 5.5 = 3.0 years gained (matches report); about 35% of the obesity-related gap closed. 已重新计算
- SMR CI symmetry – Consistent. 已重新计算
总体证据的确定性（GRADE，简化版）
- 主要结局
- Life expectancy after surgery vs general population (descriptive)
- 起始等级
- 低（观察性研究）
- 升级理由
- consistency
- large precise registry data
- 结果
- 高
由单名审查者参照 GRADE 方法进行的简化评估；并非正式的 GRADE 专家组评估。GRADE 评价的是针对某一结局的整体证据，而非单项研究。
检索策略
本次审查的文献检索记录（检索式采用原数据库语法）。
| 数据库 | 日期 | 检索式 | 检索目标 | 命中数 | 纳入数 |
|---|---|---|---|---|---|
| Europe PMC | 2026年10月26日 | (TITLE:"bariatric" OR TITLE:"sleeve gastrectomy" OR TITLE:"metabolic surgery") AND (TITLE:"mortality" OR TITLE:"survival" OR TITLE:"life expectancy") AND (PUB_TYPE:"Meta-Analysis" OR TITLE:"meta-analysis") AND PUB_YEAR:[2019 TO 2026] | 双向 | 14 | |
| PubMed | 2026年10月26日 | (bariatric surgery[tiab] OR sleeve gastrectomy[tiab]) AND (increased mortality[ti] OR excess mortality[ti] OR "mortality" [ti]) AND (external causes OR suicide OR accidents OR younger OR late mortality) | 支持性证据 | 43 |
待解决的问题
None beyond C-BAR-01.
核查深度如何？
5 项相关研究：3 项核查了全文（其中 1 项进行了结构化偏倚风险评估），2 项基于摘要核查，0 项仅核查了文献信息。 尚未进行由两名独立审查者完成的正式评估，也尚未进行独立的人类专家审核。
最近一次科学审核: 2026年10月26日
通俗解释
档案网站称，即使做了手术，瑞典患者仍比一般人群早死约 5.5 年。这个数字是正确的。但同一项研究显示，没有做手术的肥胖者比一般人群少活约 8.5 年。因此，手术增加了约 3 年的寿命；剩下的差距并不是手术造成的。重度肥胖本身就会缩短寿命。
与该说法相关的研究
支持该说法的研究 (2)
-
Swedish 24-year study: surgery added about 3 years of life
Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449队列研究被 Tayebat 档案网站引用已核查全文★ 关键研究Operated patients lived about 3 years longer than non-operated patients with obesity, but still about 5.5 years less than the general population (non-operated: about 8.5 years less).
Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Life expectancy
- 研究是如何开展的？
Prospective controlled cohort with population reference
- 研究了多少人、动物或样本？
5182 people
- 实际发现了什么？
Surgery gained 3 years; gap to population 5.5 vs 8.5 years
- 观察到的效应有多大？
HR death 0.77; +3.0 years
- 研究结果对日常生活意味着什么？
Surgery reduced but did not remove the life-expectancy loss linked to severe obesity
- 该研究有哪些局限？
Not randomized; old operations
- 它对 Elawady 的具体说法说明了什么？
Number correct, implication 'surgery shortens life' wrong
- 研究结果是否适用于德国和欧洲？
Directly European
- 从该研究中明确不能得出什么结论？
That surgery causes the remaining 5.5-year gap
-
Nordic study: survival after obesity surgery
Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048队列研究独立交叉核查已核查摘要★ 关键研究Operated people died less often than non-operated people with obesity, but more often than the general population; suicide deaths were more frequent.
Confirms operated patients still die earlier than the general population (SMR ~1.9).
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Compare survival with two reference groups
- 研究是如何开展的？
Registry cohort
- 研究了多少人、动物或样本？
505,258 (49,977 operated)
- 实际发现了什么？
HR 0.63 vs obese; SMR 1.94 vs general population
- 观察到的效应有多大？
All-cause HR 0.63; suicide HR 1.68
- 研究结果对日常生活意味着什么？
Surgery reduces but does not remove the excess risk of obesity
- 该研究有哪些局限？
Older procedures; registry data
- 它对 Elawady 的具体说法说明了什么？
Contradicts "lethal", supports "still shorter life than general population"
- 研究结果是否适用于德国和欧洲？
Direct European data
- 从该研究中明确不能得出什么结论？
Sleeve-specific long-term effects
该组中没有被标记为关键研究的研究。
与该说法相矛盾或限制该说法的研究 (2)
-
Meta-analysis: weight-loss surgery and survival
Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2Meta分析独立交叉核查已核查摘要★ 关键研究Across 174,772 people, surgery was linked to about half the risk of death and about 6 more years of median life expectancy; sleeve showed similar effects to bypass.
Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Survival
- 研究是如何开展的？
Meta-analysis of matched cohorts
- 研究了多少人、动物或样本？
174,772
- 实际发现了什么？
Lower mortality
- 观察到的效应有多大？
HR ~0.51; +6.1 years
- 研究结果对日常生活意味着什么？
Surgery is linked to longer, not shorter, life in severe obesity
- 该研究有哪些局限？
Observational studies
- 它对 Elawady 的具体说法说明了什么？
Contradicts 'lethal'
- 研究结果是否适用于德国和欧洲？
Includes Europe
- 从该研究中明确不能得出什么结论？
Exact causal size
-
Body weight and death risk worldwide
Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1Meta分析独立交叉核查全文，含结构化偏倚风险评估Severe obesity (BMI 40+) was linked to nearly 3 times the death risk of normal weight.
Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
BMI-mortality
- 研究是如何开展的？
IPD meta-analysis
- 研究了多少人、动物或样本？
~4 million
- 实际发现了什么？
Higher BMI, higher mortality
- 观察到的效应有多大？
HR 2.76 grade 3
- 研究结果对日常生活意味着什么？
Severe obesity itself shortens life
- 该研究有哪些局限？
Observational
- 它对 Elawady 的具体说法说明了什么？
Context for SOS gap
- 研究结果是否适用于德国和欧洲？
Includes Europe
- 从该研究中明确不能得出什么结论？
Effect of weight loss
该组中没有被标记为关键研究的研究。
结果不一或不明确的研究 (1)
-
40-year Utah study: deaths after weight-loss surgery
Adams et al.. Obesity (Silver Spring) 2023 · PMID 36695060 · DOI 10.1002/oby.23646队列研究独立交叉核查已核查全文★ 关键研究Overall deaths were 16% lower after surgery, but suicide was about 2.4 times more frequent, mostly in young patients.
Overall mortality 16% lower vs matched non-surgical persons.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Long-term mortality by procedure and age
- 研究是如何开展的？
Matched cohort
- 研究了多少人、动物或样本？
21,837 pairs
- 实际发现了什么？
Lower all-cause, CVD, cancer, diabetes deaths; more suicide
- 观察到的效应有多大？
HR 0.84; suicide HR 2.4
- 研究结果对日常生活意味着什么？
Benefit overall, specific mental-health risk
- 该研究有哪些局限？
Self-reported control BMI
- 它对 Elawady 的具体说法说明了什么？
Confirms suicide risk; contradicts general life-shortening
- 研究结果是否适用于德国和欧洲？
Transferable
- 从该研究中明确不能得出什么结论？
Causation
该组中没有被标记为关键研究的研究。
地区背景
德国 / 欧盟
Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.
埃及
No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.
在我的国家适用什么？
一般科学评估
基本正确 数字正确，但手术是缩小了差距，而不是造成了差距。
该说法涉及生物学或医学关系。上述科学评估不论在哪个国家都适用；各国食品数据不会改变这一评估。
参考文献
- Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study.. Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449
- Effects of Obesity Surgery on Overall and Disease-Specific Mortality in a 5-Country Population-Based Study.. Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048
- Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.. Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2
- Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.. Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1
- Long-term all-cause and cause-specific mortality for four bariatric surgery procedures.. Adams et al.. Obesity (Silver Spring) 2023 · PMID 36695060 · DOI 10.1002/oby.23646